TOG
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Obstetrician & Gynaecologist 2005;7:3:183-189
doi: 10.1576/toag.7.3.183.27098
Copyright © 2005 by the Royal College of Obstetricians and Gynaecologists.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Brien, A. L.
Right arrow Articles by Kumar, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by O'Brien, A. L.
Right arrow Articles by Kumar, S.

Review

Advances in fetal therapy

Anna Lawin O'Brien, MD, Clinical Research Fellow

Queen Charlotte's & Chelsea Hospital, London, UK

Sailesh Kumar, MMed(O&G), FRCS, MRCOG, FRANZCOG, DPhil(Oxon)

Consultant in Fetal Medicine, Centre for Fetal Care, Queen Charlotte's & Chelsea Hospital, Du Cane Road, London W12 0HS, UK email: sailesh.kumar{at}ic.ac.uk (corresponding author)

There has been steady progress in many areas of fetal medicine, not only in fetal imaging but in areas such as the management of red blood cell alloimmunisation and twin-twin transfusion syndrome, fetal surgery, genomics and stem cell research. However, many interventions that initially seemed promising have not been shown to improve fetal or neonatal morbidity or mortality. This review discusses the effectiveness of some of the newer innovations in fetal therapy.

Keywords Keywords / fetal surgery / genomics / red blood cell alloimmunisation / stem cell research / twin-twin transfusion syndrome







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Royal College of Obstetricians and Gynaecologists.